Skip to main content

Advertisement

SpringerLink
Log in

Can nuclear medicine predict response to chemotherapy?

  • Editorial
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chabner BA. The role of drugs in cancer treatment. In: Chabner BA, ed.Pharmacologic principles of cancer treatment. Philadelphia: W.B. Saunders; 1982: 3–14.

    Google Scholar 

  2. Chasseaud LF. The role of glutathione and gluthathioneS-transferases in metabolism of chemical carcinogens and other electrophilic agents.Adv Cancer Res 1979; 29: 176–274.

    Google Scholar 

  3. Saburi Y, Nakagawa M, Ono M, et al. Increased expression of glutathioneS-transferase gene incis-diamminedichloro-platinum (II) resistant variants of a Chinese hamster ovary cell line.Cancer Res 1989; 49: 7020–7025.

    Google Scholar 

  4. Liu LF. DNA topoisomerase-enzymes that catalyse the breaking and rejoining of DNA.Crit Rev Biochem 1983; 15: 1–24.

    Google Scholar 

  5. Ross WE, Sullivan DM, Chow KC, Altered function of DNA topoisomerases as a basis for antineoplastic drug action. In: De Vita VT, Hellerman S, Rosenberg SA, eds.Important advances in oncology. Philadelphia: Lippincott; 1988: 65–82.

    Google Scholar 

  6. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.Biochim Biophys Acta 1976; 455: 152–162.

    Google Scholar 

  7. Gottesman MM, Patson I. The multidrug transporter, a double-edged sword.J Biol Chem 1988; 263: 12163–12166.

    Google Scholar 

  8. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance.Annu Rev Biochem 1989; 58: 137–171.

    Google Scholar 

  9. Fojo A, Akiyama SI, Gottesman MM, et al. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines.Cancer Res 1985; 45: 3002–3007.

    Google Scholar 

  10. Shen DW, Fojo A, Chin JE, et al. Human multidrug resistant cell lines: increased MDRI expression can precede gene amplification.Science 1986; 232: 643–645.

    Google Scholar 

  11. Scotto KW, Beidler J, Malera BW. Amplification and expression of genes associated with multidrug resistance in mammalian cells.Science 1986; 232: 751–755.

    Google Scholar 

  12. Horio M, Gottesman MM, Pastan I. ATP dependent transport of vinblastine in vesicles from human multidrug resistant cells.Proc Natl Acad Sci USA 1988; 85: 3580–3584.

    Google Scholar 

  13. Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug resistant in human tumours and tissues.Proc Natl Acad Sci USA 1987; 84: 265–269.

    Google Scholar 

  14. Cordon-Cardo C, O'Brien JP, Boccia J, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumour tissues.J Histochem Cytochem 1990; 38: 1277–1287.

    Google Scholar 

  15. Chan HSL, Thorner PS, Haddad G, et al. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.J Clin Oncol 1990; 8: 689–704.

    Google Scholar 

  16. Pastan I, Gottesman M. Multiple drug resistance in human cancer.N Eng J Med 1987; 316: 1388–1392.

    Google Scholar 

  17. Brophy NA, Marie JP, Berry JM, et al. Expression of the multidrug resistance gene mdr1 in leukemia and lymphoma cells.Am Assoc Clin Oncol 1989; 8: 211.

    Google Scholar 

  18. Holzmayer TA, Hilsenbeck S, Von Hoff DD, et al. Clinical correlates of MDR (P-glycoprotein) gene expression in ovarian and small cell lung carcinomas.J Natl Cancer Inst 1992; 84: 1486–1491.

    Google Scholar 

  19. Ma DDF, Davey RA, Harman DH, et al. Detection of multidrug resistant phenotype in acute non-lymphoblastic leukemia.Lancet 1987; 1: 135–137.

    Google Scholar 

  20. Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer.Pharmacol Rev 1990; 42: 155–199.

    Google Scholar 

  21. Noonan KE, Roninson IB. Quantitative estimation of MDR1 mRNA levels by polymerase chain reaction. In: Roninson IB, ed.Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press; 1991: 319–333.

    Google Scholar 

  22. Cordon-Cardo C. Immunohistochemical analysis of P-glycoprotein expression in normal and tumor tissues in humans. In: Roninson IB, ed.Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press; 1991: 303–318.

    Google Scholar 

  23. Georges E, Bradley G, Ganepy J, Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.PNAS 1990; 87: 152–156.

    Google Scholar 

  24. Piwnica-Worms D, Chin ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organo-technetium complex.Cancer Res 1993; 53: 977–984.

    Google Scholar 

  25. Muller S, Guth-Tougelides B, Creutzig H. Imaging of malignant tumors with Tc-99m MIBI SPECT [abstract].J Nucl Med 1987; 28: 562.

    Google Scholar 

  26. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m-hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions of the lungs.Clin Nucl Med 1989; 14: 333–340.

    Google Scholar 

  27. Muller SP, Reiners C, Paas M, et al. Tc-99m MIBI T1-201 uptake in bronchial carcinoma [abstract].J Nucl Med 1989; 30: 845.

    Google Scholar 

  28. O'Tuama LA, Packard AB, Trever ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I).J Nucl Med 1990; 31: 2040–2041.

    Google Scholar 

  29. Schilacci O, Scopinaro F, Scarpini M, et al. Is Tc-99m MIBI uptake in breast cancer related to neoangiogenesis? [abstract].Eur J Nucl Med 1994; 21: 747.

    Google Scholar 

  30. Crane P, Laliberti R, Heminway S, et al. Effect of mitochondrial viability and metabolism on Tc-99m sestamibi myocardial retention.Eur J Nucl Med 1993; 20: 20–25.

    Google Scholar 

  31. Piwnica-Worms D, Kronauge JF, Chin ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence.Circulation 1990; 82: 1826–1838.

    Google Scholar 

  32. Biersack HJ, Coenen HH, Stöcklin G, et al. Imaging of brain tumors with L-3-I-123iodo-alpha-methyl tyrosine and SPECT.J Nucl Med 1989; 30: 110–112.

    Google Scholar 

  33. Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluation with FDG.J Nucl Med 1991; 32: 1555–1558.

    Google Scholar 

  34. Weber G. Enzymology of cancer cells.N Engl J Med 1977; 296: 486–493.

    Google Scholar 

  35. Okada J, Yoshiikawa K, Itami M, et al. Positron emission tomography using fluorine 18-fluorodeoxylucose in malignant lymphoma: a comparison with proliferative activity.J Nucl Med 1992, 33: 325–329.

    Google Scholar 

  36. Hoekstra OS, van Lingen A, Ossenkoppele GJ, et al. Early response monitoring in malignant lymphoma using fluorine 18 fluorodeoxyglucose single photon emission tomography.Eur J Nucl Med 1993; 20: 1214–1217.

    Google Scholar 

  37. Duran Cordobes M, Blanchot C, Delmon-Moingeon JC, et al. Tc-99m MIBI uptake by a series of human benign and malignant breast tumor cells: correlation with gene MDR expression. Abstracts of the 6th World Congress of Nuclear Medicine and Biology, Sydney, October 1994.Eur J Nucl Med 21 [Suppl]: ppS8

  38. Herman LW, Rao V Barbarics E, et al. Imaging and modulation of multidrug resistance P-glycoprotein (PGP) transport function with novel hexakis (arylisonitrile) Tc complexes [abstract].J Nucl Med 1994; 35: 19P.

Download references

Author information

Authors and Affiliations

  1. Service de Médecine Nucléaire et d'Oncologie, Hopital Avicenne CHU Bobigny, Universite Paris XIII, France

    Jean-Luc Moretti, Meltem Caglar, Muriel Duran-Cordobes & Jean-François Morere

Authors
  1. Jean-Luc Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meltem Caglar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muriel Duran-Cordobes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-François Morere
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moretti, JL., Caglar, M., Duran-Cordobes, M. et al. Can nuclear medicine predict response to chemotherapy?. Eur J Nucl Med 22, 97–100 (1995). https://doi.org/10.1007/BF00838937

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00838937

Search

Navigation